Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 8

Dysfunctional lung anatomy and small airways degeneration in COPD

Authors Martin C, Frija J, Burgel PR

Received 15 November 2012

Accepted for publication 30 November 2012

Published 4 January 2013 Volume 2013:8 Pages 7—13

DOI https://doi.org/10.2147/COPD.S28290

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2

Clémence Martin, Justine Frija, Pierre-Régis Burgel

Department of Respiratory Medicine, Cochin Hospital, AP-HP and Université Paris Descartes, Sorbonne Paris Cité, Paris, France

Abstract: Chronic obstructive pulmonary disease (COPD) is characterized by incompletely reversible airflow obstruction. Direct measurement of airways resistance using invasive techniques has revealed that the site of obstruction is located in the small conducting airways, ie, bronchioles with a diameter < 2 mm. Anatomical changes in these airways include structural abnormalities of the conducting airways (eg, peribronchiolar fibrosis, mucus plugging) and loss of alveolar attachments due to emphysema, which result in destabilization of these airways related to reduced elastic recoil. The relative contribution of structural abnormalities in small conducting airways and emphysema has been a matter of much debate. The present article reviews anatomical changes and inflammatory mechanisms in small conducting airways and in the adjacent lung parenchyma, with a special focus on recent anatomical and imaging data suggesting that the initial event takes place in the small conducting airways and results in a dramatic reduction in the number of airways, together with a reduction in the cross-sectional area of remaining airways. Implications of these findings for the development of novel therapies are briefly discussed.

Keywords: emphysema, small airways disease, airway mucus, innate immunity, adaptive immunity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other article by this author:

Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy

Burgel PR, Paugam A, Hubert D, Martin C

Infection and Drug Resistance 2016, 9:229-238

Published Date: 20 September 2016

Readers of this article also read:

Chronic obstructive pulmonary disease exacerbation frequency and severity

Stafyla E, Kerenidi T, Gourgoulianis KI

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:533-535

Published Date: 6 November 2013

The association between COPD and heart failure risk: a review

de Miguel Díez J, Chancafe Morgan J, Jiménez García R

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:305-312

Published Date: 28 June 2013

A comparison of three multidimensional indices of COPD severity as predictors of future exacerbations

Motegi T, Jones RC, Ishii T, Hattori K, Kusunoki Y, Furutate R, Yamada K, Gemma A, Kida K

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:259-271

Published Date: 31 May 2013

Symptom variability in COPD: a narrative review

Lopez-Campos JL, Calero C, Quintana-Gallego E

International Journal of Chronic Obstructive Pulmonary Disease 2013, 8:231-238

Published Date: 7 May 2013

Correlates of COPD and chronic bronchitis in nonsmokers: data from a cross-sectional study

Waked M, Salame J, Khayat G, Salameh P

International Journal of Chronic Obstructive Pulmonary Disease 2012, 7:577-585

Published Date: 7 September 2012